Definitive Healthcare (NASDAQ:DH) Receives New Coverage from Analysts at BTIG Research

BTIG Research began coverage on shares of Definitive Healthcare (NASDAQ:DH) in a research report released on Tuesday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $7.00 target price on the stock.

Several other analysts have also commented on the stock. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Definitive Healthcare from $7.00 to $5.00 and set a hold rating on the stock in a research report on Friday, August 9th. JPMorgan Chase & Co. downgraded Definitive Healthcare from a neutral rating to an underweight rating and dropped their price target for the stock from $7.00 to $5.00 in a research report on Wednesday, July 31st. Barclays reduced their price objective on Definitive Healthcare from $6.00 to $4.00 and set an equal weight rating on the stock in a research report on Wednesday, August 7th. Robert W. Baird dropped their price objective on Definitive Healthcare from $6.00 to $5.00 and set a neutral rating for the company in a research report on Wednesday, August 7th. Finally, Morgan Stanley reduced their target price on shares of Definitive Healthcare from $9.00 to $5.00 and set an equal weight rating on the stock in a report on Tuesday, August 6th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, Definitive Healthcare currently has a consensus rating of Hold and an average target price of $5.81.

Definitive Healthcare Stock Performance

Shares of DH opened at $4.74 on Tuesday. The company has a market capitalization of $559.01 million, a PE ratio of -2.71, a P/E/G ratio of 6.38 and a beta of 1.33. Definitive Healthcare has a 52-week low of $3.19 and a 52-week high of $10.62. The company has a 50-day simple moving average of $4.66 and a 200-day simple moving average of $5.92. The company has a quick ratio of 2.40, a current ratio of 2.40 and a debt-to-equity ratio of 0.27.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings results on Monday, August 5th. The company reported $0.09 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.09. The company had revenue of $63.70 million during the quarter, compared to the consensus estimate of $63.19 million. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. The company’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same period last year, the firm earned $0.08 EPS. Equities research analysts predict that Definitive Healthcare will post 0.07 earnings per share for the current fiscal year.

Institutional Trading of Definitive Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the company. Swiss National Bank increased its position in Definitive Healthcare by 2.9% during the 1st quarter. Swiss National Bank now owns 103,300 shares of the company’s stock worth $834,000 after purchasing an additional 2,900 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of Definitive Healthcare by 17.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock valued at $125,000 after acquiring an additional 3,332 shares during the period. Principal Financial Group Inc. lifted its holdings in shares of Definitive Healthcare by 10.8% during the 2nd quarter. Principal Financial Group Inc. now owns 39,856 shares of the company’s stock valued at $218,000 after acquiring an additional 3,874 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Definitive Healthcare by 31.4% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock worth $116,000 after purchasing an additional 5,083 shares during the period. Finally, Valeo Financial Advisors LLC increased its holdings in Definitive Healthcare by 11.8% in the 2nd quarter. Valeo Financial Advisors LLC now owns 59,080 shares of the company’s stock valued at $323,000 after purchasing an additional 6,230 shares in the last quarter. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.